UniProt ID | TEAD4_HUMAN | |
---|---|---|
UniProt AC | Q15561 | |
Protein Name | Transcriptional enhancer factor TEF-3 | |
Gene Name | TEAD4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 434 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and non-cooperatively to the Sph and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription. Binds to the M-CAT motif.. | |
Protein Sequence | MEGTAGTITSNEWSSPTSPEGSTASGGSQALDKPIDNDAEGVWSPDIEQSFQEALAIYPPCGRRKIILSDEGKMYGRNELIARYIKLRTGKTRTRKQVSSHIQVLARRKAREIQAKLKDQAAKDKALQSMAAMSSAQIISATAFHSSMALARGPGRPAVSGFWQGALPGQAGTSHDVKPFSQQTYAVQPPLPLPGFESPAGPAPSPSAPPAPPWQGRSVASSKLWMLEFSAFLEQQQDPDTYNKHLFVHIGQSSPSYSDPYLEAVDIRQIYDKFPEKKGGLKDLFERGPSNAFFLVKFWADLNTNIEDEGSSFYGVSSQYESPENMIITCSTKVCSFGKQVVEKVETEYARYENGHYSYRIHRSPLCEYMINFIHKLKHLPEKYMMNSVLENFTILQVVTNRDTQETLLCIAYVFEVSASEHGAQHHIYRLVKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
44 | Phosphorylation | NDAEGVWSPDIEQSF CCCCCCCCCCHHHHH | 15.41 | 25627689 | |
65 | Ubiquitination | YPPCGRRKIILSDEG CCCCCCCEEEECCCC | 32.51 | 29967540 | |
69 | Phosphorylation | GRRKIILSDEGKMYG CCCEEEECCCCCEEC | 24.17 | 30266825 | |
73 | Ubiquitination | IILSDEGKMYGRNEL EEECCCCCEECHHHH | 27.22 | 21890473 | |
73 | Ubiquitination | IILSDEGKMYGRNEL EEECCCCCEECHHHH | 27.22 | 23000965 | |
84 | Phosphorylation | RNELIARYIKLRTGK HHHHHHHHHHHHCCC | 8.06 | 21403953 | |
91 | Methylation | YIKLRTGKTRTRKQV HHHHHCCCCCCHHHH | 33.93 | - | |
96 | Ubiquitination | TGKTRTRKQVSSHIQ CCCCCCHHHHHHHHH | 55.21 | - | |
123 | Acetylation | KLKDQAAKDKALQSM HHHHHHHHHHHHHHH | 63.88 | 30592899 | |
134 | Phosphorylation | LQSMAAMSSAQIISA HHHHHHHHHHHHHHH | 20.14 | 25332170 | |
135 | Phosphorylation | QSMAAMSSAQIISAT HHHHHHHHHHHHHHH | 15.88 | 24043423 | |
140 | Phosphorylation | MSSAQIISATAFHSS HHHHHHHHHHHHHHH | 22.61 | 24043423 | |
142 | Phosphorylation | SAQIISATAFHSSMA HHHHHHHHHHHHHHH | 24.06 | 25332170 | |
146 | Phosphorylation | ISATAFHSSMALARG HHHHHHHHHHHHHHC | 18.50 | 24043423 | |
147 | Phosphorylation | SATAFHSSMALARGP HHHHHHHHHHHHHCC | 10.25 | 24043423 | |
153 | Ubiquitination | SSMALARGPGRPAVS HHHHHHHCCCCCCCC | 24.33 | 29967540 | |
178 | Sumoylation | AGTSHDVKPFSQQTY CCCCCCCCCCCCCEE | 46.53 | - | |
185 | Phosphorylation | KPFSQQTYAVQPPLP CCCCCCEEECCCCCC | 10.63 | 28102081 | |
198 | Phosphorylation | LPLPGFESPAGPAPS CCCCCCCCCCCCCCC | 20.14 | 25159151 | |
205 | Phosphorylation | SPAGPAPSPSAPPAP CCCCCCCCCCCCCCC | 33.33 | 26657352 | |
207 | Phosphorylation | AGPAPSPSAPPAPPW CCCCCCCCCCCCCCC | 58.72 | 28102081 | |
210 | Ubiquitination | APSPSAPPAPPWQGR CCCCCCCCCCCCCCC | 58.05 | 32142685 | |
239 | Ubiquitination | FLEQQQDPDTYNKHL HHHHCCCCCCCCCEE | 31.35 | 29967540 | |
253 | Phosphorylation | LFVHIGQSSPSYSDP EEEEECCCCCCCCCC | 38.72 | 25159151 | |
254 | Phosphorylation | FVHIGQSSPSYSDPY EEEECCCCCCCCCCH | 15.24 | 20873877 | |
256 | Phosphorylation | HIGQSSPSYSDPYLE EECCCCCCCCCCHHH | 38.94 | 20873877 | |
257 | Phosphorylation | IGQSSPSYSDPYLEA ECCCCCCCCCCHHHE | 22.07 | 29523821 | |
258 | Phosphorylation | GQSSPSYSDPYLEAV CCCCCCCCCCHHHEE | 36.13 | 20873877 | |
261 | Phosphorylation | SPSYSDPYLEAVDIR CCCCCCCHHHEEEHH | 23.36 | 20873877 | |
271 | Phosphorylation | AVDIRQIYDKFPEKK EEEHHHHHHHCCHHC | 12.54 | - | |
273 | Ubiquitination | DIRQIYDKFPEKKGG EHHHHHHHCCHHCCC | 45.94 | - | |
278 | Acetylation | YDKFPEKKGGLKDLF HHHCCHHCCCHHHHH | 57.45 | 18528523 | |
282 | Ubiquitination | PEKKGGLKDLFERGP CHHCCCHHHHHHHCC | 56.51 | 29967540 | |
282 | Acetylation | PEKKGGLKDLFERGP CHHCCCHHHHHHHCC | 56.51 | 18528531 | |
296 | Ubiquitination | PSNAFFLVKFWADLN CCCCEEEEEEEHHCC | 3.98 | 32142685 | |
315 | Phosphorylation | DEGSSFYGVSSQYES CCCCCCCCCCCCCCC | 15.72 | 10764782 | |
322 | Phosphorylation | GVSSQYESPENMIIT CCCCCCCCCCCEEEE | 32.36 | 10764782 | |
335 | S-palmitoylation | ITCSTKVCSFGKQVV EEEECEEECCCHHHH | 2.73 | 31043565 | |
339 | Ubiquitination | TKVCSFGKQVVEKVE CEEECCCHHHHHHHH | 37.60 | 32142685 | |
347 | Phosphorylation | QVVEKVETEYARYEN HHHHHHHHHHHHHHC | 36.96 | 28152594 | |
349 | Phosphorylation | VEKVETEYARYENGH HHHHHHHHHHHHCCC | 12.09 | 28152594 | |
352 | Phosphorylation | VETEYARYENGHYSY HHHHHHHHHCCCEEE | 12.94 | - | |
357 | Phosphorylation | ARYENGHYSYRIHRS HHHHCCCEEEEEECC | 14.59 | - | |
358 | Phosphorylation | RYENGHYSYRIHRSP HHHCCCEEEEEECCH | 11.40 | 24719451 | |
367 | S-palmitoylation | RIHRSPLCEYMINFI EEECCHHHHHHHHHH | 3.90 | 31043565 | |
420 | Phosphorylation | YVFEVSASEHGAQHH EEEEECCCHHHHHHH | 23.71 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TEAD4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TEAD4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TEAD4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...